Aigen Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,823
| Closed | -$228K | – | 981 |
|
|
2024
Q3 | $228K | Sell |
1,823
-7,994
| -81% | -$998K | 0.04% | 541 |
|
|
2024
Q2 | $1.55M | Buy |
9,817
+8,106
| +474% | +$1.28M | 0.3% | 81 |
|
|
2024
Q1 | $222K | Sell |
1,711
-1,560
| -48% | -$202K | 0.05% | 521 |
|
|
2023
Q4 | $315K | Buy |
+3,271
| New | +$315K | 0.06% | 467 |
|
|
2023
Q3 | – | Sell |
-4,428
| Closed | -$507K | – | 1073 |
|
|
2023
Q2 | $507K | Sell |
4,428
-8,428
| -66% | -$965K | 0.07% | 345 |
|
|
2023
Q1 | $1.77M | Sell |
12,856
-5,606
| -30% | -$773K | 0.24% | 105 |
|
|
2022
Q4 | $2.39M | Buy |
18,462
+6,608
| +56% | +$856K | 0.34% | 80 |
|
|
2022
Q3 | $1.31M | Buy |
+11,854
| New | +$1.31M | 0.19% | 157 |
|
|
2022
Q2 | – | Sell |
-3,209
| Closed | -$251K | – | 710 |
|
|
2022
Q1 | $251K | Buy |
+3,209
| New | +$251K | 0.04% | 427 |
|
|
2021
Q2 | – | Sell |
-18,621
| Closed | -$1.39M | – | 718 |
|
|
2021
Q1 | $1.39M | Buy |
+18,621
| New | +$1.39M | 0.18% | 134 |
|
|
2020
Q4 | – | Sell |
-2,972
| Closed | -$417K | – | 1029 |
|
|
2020
Q3 | $417K | Buy |
+2,972
| New | +$417K | 0.05% | 441 |
|